Two films opening on 9 October arrive from opposite ends of the commercial map: Other Mommy, launching in more than 3,200 North American theatres with an opening forecast around 20 million dollars, and The Social Reckoning, opening wide to forecasts clustered between seven and eight million — a gap that defines the weekend before a ticket is sold.
The tracking behind those numbers has converged from different directions: trade forecasting services put the sequel-adjacent drama in the high single digits at best, with earlier ranges stretching only to ten million, while the horror title’s theatre count and pre-sales support its position at the top of the new releases. Last weekend’s champion, in its second weekend, is projected around twelve million, which would place it between the two newcomers and underline how soft the reckoning’s opening is expected to be.
Reviews explain part of the caution. The Social Reckoning stands at 64 per cent with critics, early notices praising the performances of Mikey Madison, Jeremy Allen White and Jeremy Strong while questioning whether the film finds enough that is new in material audiences have spent years discussing. Its predecessor is one of the most admired films of its generation, and sequels-by-continuation to canonical titles carry a burden no marketing can remove: every reviewer, and much of the audience, arrives comparing.
For its studio, the equation is theatrical arithmetic. A film positioned as prestige counter-programming cannot rely on opening ubiquity; it needs awards conversation and word of mouth to leg out, and a seven-million-dollar start leaves little margin if either fails to arrive. Other Mommy’s task is simpler and more forgiving — satisfy the genre audience this weekend, at scale, and let the calendar’s horror-friendly month do the rest.
Morning readers choosing a cinema trip have the market’s own summary: the crowd will be at the horror title, the argument will be about the reckoning. Box-office history favours the crowd. Prestige history occasionally embarrasses it. Monday’s actuals will record which instinct October rewarded.
Exhibitors, quietly, are rooting for both: a horror title to fill the weekend and a prestige title to leg into awards season and fill the winter. The forecasts say they will get one wish. Monday’s grosses, and the second-weekend holds they imply, will tell them whether the other was ever realistic.
